Damian Swieczkowski
Overview
Explore the profile of Damian Swieczkowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pruc M, Swieczkowski D, Cander B, Jaguszewski M, Galwankar S, Di Somma S, et al.
Cardiol J
. 2025 Feb;
PMID: 39976389
Background: The role of Cystatin C (CysC) in the diagnosis and prognosis of cardiovascular disease, particularly acute coronary syndrome (ACS), is increasingly significant. The goal of this meta-analysis was to...
2.
Pastuszak M, Cubala W, Jakuszkowiak-Wojten K, Kwasny A, Swieczkowski D, Galuszko-Wegielnik M
Neuropsychopharmacol Rep
. 2025 Jan;
45(1):e12519.
PMID: 39783764
Background: Residual fatigue is a common and debilitating symptom in patients with unipolar and bipolar depression, even after achieving partial or full remission. It significantly impacts patients' quality of life...
3.
Swieczkowski D, Kwasny A, Pruc M, Gaca Z, Szarpak P, Szarpak L, et al.
Psychiatry Res
. 2025 Jan;
344():116337.
PMID: 39754904
Selecting the optimal dose of psilocybin for treating Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD) is crucial for clinical development and regulatory approval. This meta-analysis evaluates psilocybin's efficacy and...
4.
Pruc M, Kubica J, Banach M, Swieczkowski D, Rafique Z, Peacock W, et al.
Kardiol Pol
. 2024 Oct;
83(1):52-61.
PMID: 39377620
Background: Globally, diseases of the cardiovascular system stand as principal contributors to mortality and are expected to show an upward trajectory. The occurrence of acute coronary syndrome (ACS) has been...
5.
Swieczkowski D, Pruc M, Szarpak L
Am J Emerg Med
. 2024 Oct;
86:150-151.
PMID: 39368866
No abstract available.
6.
Pruc M, Kurek K, Swieczkowski D, Szarpak L
Intensive Care Med
. 2024 Aug;
50(11):1957-1958.
PMID: 39141087
No abstract available.
7.
Pruc M, Gaca Z, Swieczkowski D, Kubica J, Galwankar S, Salak A, et al.
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124770
We investigated the potential diagnostic role of galectin-3 (Gal-3) in patients presenting with suspected acute coronary syndromes (ACS). We searched PubMed Central, Scopus, EMBASE, and the Cochrane Library from inception...
8.
Gaca Z, Pruc M, Swieczkowski D, Kwasny A, Szarpak L, Cubala W
Eur Neuropsychopharmacol
. 2024 Jun;
86():18-19.
PMID: 38917770
No abstract available.
9.
Pruc M, Kubica J, Banach M, Swieczkowski D, Rafique Z, Peacock W, et al.
Kardiol Pol
. 2024 Mar;
82(3):276-284.
PMID: 38493452
Background: Cardiovascular disease is a leading cause of mortality worldwide and is likely to rise. Acute coronary syndrome (ACS) is consequent on inflammation. As a common and cost-effective inflammatory biomarker,...
10.
Krawczyk A, Kurek K, Nucera G, Pruc M, Swieczkowski D, Kacprzyk D, et al.
Cardiol J
. 2024 Jan;
32(1):9-18.
PMID: 38247439
Background: The importance of bystander cardiopulmonary resuscitation (CPR) during out-of-hospital cardiac arrests is especially important in the context of coronavirus disease 2029 (COVID-19) because it can significantly influence survival outcomes....